Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 34
Filter
Add more filters










Publication year range
1.
Toxicol Lett ; 326: 61-69, 2020 Jun 15.
Article in English | MEDLINE | ID: mdl-32169443

ABSTRACT

Notch-1 intervenes in the reparative processes of mucosa by controlling cell proliferation, differentiation and stem cell maintenance. Cigarette smoke alters airway epithelial homeostasis. The present study explored whether: Smokers showed altered Notch-1 expression; and whether in bronchial epithelial cells (16HBE): a) cigarette smoke extracts (CSE) altered the expression of Notch-1, of its ligand Jagged-1 (Jag-1) and the nuclear translocation of Notch-1; b) Notch-1 signaling activation as well as CSE modified Ki67, PCNA, p21, IL-33 expression, cell proliferation and repair processes. Notch-1 expression was assessed in the epithelium from large airway surgical samples from non-smoker and smoker subjects by immunohistochemistry.16HBE were cultured with/without CSE and Jag-1. A Notch-1 inhibitor (DAPT) was used as control. The expression of Notch-1, Jag-1, Ki67, PCNA, p21, IL-33 and cell proliferation (by CFSE) were all assessed by flow cytometry. Notch-1 nuclear expression was evaluated by immunofluorescence and western blot analysis. Repair processes were assessed by wound assay. Smokers had cytoplasmic but not nuclear Notch-1 expression. Although CSE increased Notch-1 expression, it counteracted Notch-1 signaling activation since it reduced Jag-1 expression and Notch-1 nuclear translocation. Notch-1 signaling activation by Jag-1 increased Ki67, PCNA and repair processes but reduced intracellular IL-33 and p21 expression without affecting cell proliferation. DAPT counteracted the effects of Notch-1 activation on PCNA and IL-33. CSE increased Ki67, PCNA, p21 and IL-33 expression but reduced cell proliferation and repair processes. In conclusion, cigarette smoke exposure, limiting Notch-1 signaling activation and hindering repair processes, amplifies injury processes in bronchial epithelial cells.


Subject(s)
Apoptosis/drug effects , Bronchi/drug effects , Cell Proliferation/drug effects , Epithelial Cells/drug effects , Receptors, Notch/drug effects , Signal Transduction/drug effects , Tobacco Smoke Pollution/adverse effects , Humans
2.
J Cell Physiol ; 234(4): 4582-4596, 2019 04.
Article in English | MEDLINE | ID: mdl-30259982

ABSTRACT

BACKGROUND: Alterations in the nasal epithelial barrier homeostasis and increased interleukin 33 (IL-33) expression contribute to the pathogenesis of chronic rhinosinusitis with nasal polyps (CRSwNP). AIMS: As Notch-1 signaling is crucial in repair processes of mucosa, the current study assessed Notch-1/Jagged-1 signaling and IL-33 in the epithelium of nasal polyps biopsies from allergic (A-CRSwNP; n = 9) and not allergic (NA-CRSwNP; n = 9) subjects by immunohistochemistry. We also assessed, in a model of nasal epithelial cells, the effects of stimulation of Notch-1 with Jagged-1 on the expression of IL-33 (by flow cytometry, immunofluorescence, and immunocytochemistry), Jagged-1 (by flow cytometry), and p-CREB transcription factor (by western blot analysis). RESULTS: Ex vivo (a) in normal epithelium, the expression of Notch-1 and IL-33 were higher in NA-CRSwNP than in A-CRSwNP; (b) in metaplastic epithelium, the expression of Notch-1, Jagged-1, and IL-33 were higher in NA-CRSwNP than in A-CRSwNP; (c) in hyperplastic epithelium, the expression of Notch-1, Jagged-1, and IL-33 were higher in A-CRSwNP than in NA-CRSwNP; and (d) in basal epithelial cells, no differences were observed in the expression of Jagged-1, IL-33, and Notch-1. The expression of Notch-1 significantly correlated with the expression of IL-33. In vitro, stimulation of Notch-1 with Jagged-1 induced the expression of (a) Jagged-1; (b) IL-33; and (c) p-CREB transcription factor. The inhibitor of Notch-1, DAPT, reduced all the effects of Jagged-1 on nasal epithelial cells. CONCLUSIONS: The data herein provided support, for the first time, a putative role of Notch-1/Jagged-1 signaling in the overexpression of IL-33 in the epithelium of nasal polyps from patients with CRSwNP.


Subject(s)
Epithelial Cells/metabolism , Interleukin-33/metabolism , Nasal Mucosa/metabolism , Nasal Polyps/metabolism , Receptor, Notch1/metabolism , Rhinitis, Allergic/metabolism , Sinusitis/metabolism , Adult , Cell Line , Chronic Disease , Cyclic AMP Response Element-Binding Protein/metabolism , Epithelial Cells/immunology , Epithelial Cells/pathology , Female , Humans , Jagged-1 Protein/metabolism , Male , Middle Aged , Nasal Mucosa/immunology , Nasal Mucosa/pathology , Nasal Polyps/immunology , Nasal Polyps/pathology , Phosphorylation , Rhinitis, Allergic/immunology , Rhinitis, Allergic/pathology , Signal Transduction , Sinusitis/immunology , Sinusitis/pathology , Up-Regulation , Young Adult
3.
Allergy ; 67(7): 878-86, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22583192

ABSTRACT

BACKGROUND: Chronic rhinosinusitis (CRS) is an inflammation of the nose and of the paranasal sinuses. The involvement of the respiratory epithelium in the mechanisms of CRS is poorly understood. AIMS: Among proteins expressed by nasal epithelial cells in CRS, IL-19 may have key functions. We here aimed to determine the expression and regulation of IL-19. METHODS: Nasal biopsies from normal subjects (n = 12), subjects with CRS but without nasal polyps (NP) (CRSsNP, n = 12) and with CRS with NP (CRSwNP, n = 15) were collected. Human Asthma Gene Array and real-time PCR were used to evaluate gene expression, western blot analysis and immunohistochemistry for protein expression. Results for IL-19 were confirmed by real-time PCR. The constitutive and stimulated (LPS, TGF ß) expression of IL-19 and cell proliferation were evaluated in a nasal epithelial cell line (RPMI 2650). RESULTS: Human Asthma Gene Array showed an increased IL-19 gene expression in NP from patients with CRS in comparison with normal subjects. Real-time PCR confirmed the IL-19 mRNA up-regulation in patients with CRSwNP and showed an up-regulation of IL-19, at lower extent, in patients with chronic rhinosinusitis without nasal polyps (CRSsNP) in comparison with normal subjects. Western blot analysis confirmed that IL-19 is increased also at protein level in patients with CRSwNP in comparison with normal subjects. In NP, IL-19 is highly expressed in the metaplastic nasal epithelium when compared to normal or hyperplastic epithelium. LPS stimulation increased IL-19 expression, and recombinant IL-19 increased cell proliferation in nasal epithelial cells. CONCLUSIONS: IL-19 is overexpressed in the epithelium in CRSwNP and increases epithelial cell proliferation.


Subject(s)
Interleukins/metabolism , Nasal Mucosa/immunology , Nasal Polyps/immunology , Rhinitis/immunology , Sinusitis/immunology , Adolescent , Adult , Chronic Disease , Epithelial Cells/metabolism , Female , Gene Expression , Gene Expression Profiling , Humans , Interleukins/genetics , Ki-67 Antigen/genetics , Ki-67 Antigen/metabolism , Male , Middle Aged , Nasal Mucosa/metabolism , Nasal Polyps/genetics , RNA, Messenger/metabolism , Rhinitis/genetics , Sinusitis/genetics , Young Adult
4.
Allergy ; 62(7): 787-94, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17573727

ABSTRACT

BACKGROUND: Chromatin modification may play a role in inflammatory gene regulation in asthma. Cyclic adenosine mono-phosphate response element-binding protein (CREB), with the specific co-activator, the CREB-binding protein (CBP), contributes to the acetylation of chromatin and to the transcription of pro-inflammatory genes. OBJECTIVES: To evaluate the expression of CBP and of phospho-CREB (p-CREB) in bronchial biopsies and in peripheral blood mononuclear cells (PBMC) of controls (C), untreated (UA), inhaled steroid treated (ICS) and steroid-dependent asthmatic (SDA) patients. METHODS: We used immunohistochemistry in bronchial biopsies and western blot analysis and immunocytochemistry in PBMC. RESULTS: Cyclic adenosine mono-phosphate response element-binding protein expression, in the epithelium was similar in all groups, while p-CREB expression was increased in UA and in SDA in comparison with ICS and C subjects (C vs UA P = 0.002, C vs SDA P = 0.007), (ICS vs SDA P = 0.005), (ICS vs UA P = 0.001). Interestingly, also in the submucosa, p-CREB was increased in UA and SDA in comparison with ICS and C subjects (C vs UA P = 0.0004) (C vs SDA P < 0.0001) (ICS vs UA P = 0.002) (ICS vs SDA P < 0.0001) and positively correlated with leukocyte infiltration within the bronchi (CD45RB+ cells). Similar results were obtained with PBMC isolated from the same patient groups. Incubation of PBMC in vitro, with fluticasone propionate, decreased the p-CREB expression induced by cytokine activation (interferon-gamma, tumor necrosis factor-alpha). CONCLUSIONS: This study demonstrates that the expression of p-CREB is related, in asthma, to the persistent inflammation according to the disease severity. p-CREB expression can be modulated by glucocorticoids in responsive patients.


Subject(s)
Asthma/pathology , Cyclic AMP Response Element-Binding Protein/analysis , Inflammation/diagnosis , Severity of Illness Index , Adult , Cyclic AMP Response Element-Binding Protein/genetics , Female , Gene Expression Regulation/drug effects , Glucocorticoids/pharmacology , Humans , Immunohistochemistry , Male , Middle Aged , Phenotype , Phosphorylation , Tissue Distribution
5.
Eur Respir J ; 26(3): 398-405, 2005 Sep.
Article in English | MEDLINE | ID: mdl-16135719

ABSTRACT

The leptin-leptin receptor system might be up-regulated in the airways of chronic obstructive pulmonary disease (COPD). In bronchial biopsies obtained from normal subjects and smokers, with and without COPD, the present study examined leptin and leptin-receptor expression and their co-localisation in airway and inflammatory cells. Combining immunohistochemistry with terminal deoxynucleotidyl transferase dUTP nick end-labelling techniques, apoptosis in airway and inflammatory cells and in leptin and leptin-receptor expressing cells was investigated. In the epithelial cells both leptin and leptin-receptor expression was higher in normal subjects than in smokers and COPD subjects. By contrast, in the sub-mucosa, leptin was over-expressed in COPD when compared with normal subjects and smokers. Leptin and its receptor were co-localised, mainly with activated T cells (CD45R0) and CD8+ T lymphocytes. In smokers, apoptosis was found in some inflammatory cells, whereas in COPD inflammatory cells, leptin and leptin-receptor positive cells were not apoptotic. Leptin expression was related to COPD severity and assessed using the Global initiative for Chronic Obstructive Lung Disease classification. In conclusion, the present study shows an increased leptin expression in bronchial mucosa of chronic obstructive pulmonary disease patients, associated with airway inflammation and airflow obstruction.


Subject(s)
Bronchi/metabolism , Leptin/metabolism , Pulmonary Disease, Chronic Obstructive/metabolism , Receptors, Cell Surface/metabolism , Respiratory Mucosa/metabolism , Smoking/metabolism , Adult , Aged , Apoptosis/physiology , Bronchi/pathology , Case-Control Studies , Female , Humans , Male , Middle Aged , Pulmonary Disease, Chronic Obstructive/pathology , Receptors, Leptin , Respiratory Function Tests , Respiratory Mucosa/pathology , T-Lymphocytes/physiology
6.
Thorax ; 59(4): 303-7, 2004 Apr.
Article in English | MEDLINE | ID: mdl-15047949

ABSTRACT

BACKGROUND: To investigate whether nasal and bronchial inflammation coexists in chronic obstructive pulmonary disease (COPD), nasal and bronchial biopsy specimens from seven control subjects, seven smokers without COPD, and 14 smokers with COPD were studied. METHODS: Nasal and bronchial biopsy specimens were taken from the same patients during bronchoscopy and squamous cell metaplasia and the thickness of the epithelium and basement membrane were measured. The numbers of eosinophils (EG2), neutrophils (elastase), macrophages (CD68), and CD8 T lymphocytes (CD8/144B) were assessed by immunohistochemistry. RESULTS: Smokers with and without COPD had squamous metaplasia in the nasal and bronchial epithelium. In all groups the thickness of the nasal epithelium was greater than that of the bronchial epithelium. The thickness of the basement membrane was similar in nasal and bronchial biopsy specimens from smokers with and without COPD, but was greater in the bronchi than in the nasal epithelium of controls. Eosinophil number was higher in the nasal and bronchial mucosa of smokers without COPD than in smokers with COPD or controls. Neutrophil number was higher in the nasal and bronchial mucosa of smokers with COPD than in smokers without COPD or controls. CD8 T lymphocyte numbers were similar in smokers with and without COPD and higher than in controls. There were fewer macrophages in nasal and bronchial biopsy specimens from smokers without COPD than in those with COPD. CONCLUSION: Nasal and bronchial inflammation coexists in smokers and is characterised by infiltration of CD8 T lymphocytes. In smokers without COPD this feature is associated with an increased number of eosinophils, while in those with COPD it is linked to an increased number of neutrophils in both nasal and bronchial biopsy specimens.


Subject(s)
Nasal Mucosa/pathology , Pulmonary Disease, Chronic Obstructive/pathology , Smoking/pathology , Adult , Basement Membrane/pathology , CD8-Positive T-Lymphocytes/pathology , Eosinophils/pathology , Female , Humans , Macrophages/pathology , Male , Metaplasia/pathology , Middle Aged , Neutrophils/pathology , Rhinitis/pathology
7.
Thorax ; 58(7): 573-9, 2003 Jul.
Article in English | MEDLINE | ID: mdl-12832668

ABSTRACT

BACKGROUND: Inflammation in chronic obstructive pulmonary disease (COPD) is characterised by increased neutrophilic infiltration of the airways. Cilomilast, a novel selective phosphodiesterase 4 inhibitor in clinical development for COPD treatment, exerts anti-inflammatory effects. The ability of cilomilast to inhibit the release of neutrophil chemoattractants such as tumour necrosis factor (TNF)-alpha, interleukin (IL)-8, and granulocyte-macrophage colony stimulating factor (GM-CSF) by bronchial epithelial cells and sputum cells isolated from 10 patients with COPD, 14 normal controls, and 10 smokers was investigated. METHODS: Bronchial epithelial cells obtained by bronchial brushing and sputum cells isolated from induced sputum samples were cultured for 24 hours in the presence or absence of cilomilast (1 micro M). After incubation the supernatants were harvested and the levels of mediators measured by ELISA. Chemotactic activity in supernatants was also measured using a Boyden chamber. RESULTS: TNF-alpha and IL-8 release by bronchial epithelial cells and sputum cells was higher in patients with COPD than in controls (p<0.0001) and smokers (p<0.0001). GM-CSF was only detectable in sputum cell supernatants and its level was higher in patients with COPD than in controls and smokers (p<0.0001, respectively). Cilomilast significantly reduced TNF-alpha release by bronchial epithelial cells and sputum cells (p=0.005) and GM-CSF release by sputum cells (p=0.003), whereas IL-8 release was not statistically inhibited. Supernatants of sputum cells and bronchial epithelial cells treated with cilomilast significantly decreased neutrophil chemotaxis (p<0.006 and p<0.008, respectively). CONCLUSIONS: Cilomilast inhibits the production of some neutrophil chemoattractants by airway cells. This drug may play a role in the resolution of neutrophilic inflammation associated with COPD and cigarette smoke.


Subject(s)
Bronchodilator Agents/therapeutic use , Granulocyte-Macrophage Colony-Stimulating Factor/metabolism , Interleukin-8/metabolism , Phosphodiesterase Inhibitors/therapeutic use , Pulmonary Disease, Chronic Obstructive/drug therapy , Sputum/cytology , Adult , Aged , Carboxylic Acids , Cell Count , Cells, Cultured , Chemotaxis, Leukocyte , Cyclohexanecarboxylic Acids , Enzyme-Linked Immunosorbent Assay , Epithelial Cells/metabolism , Female , Humans , Male , Middle Aged , Nitriles , Pulmonary Disease, Chronic Obstructive/metabolism , Respiratory Mucosa/metabolism , Tumor Necrosis Factor-alpha
8.
Paediatr Respir Rev ; 3(1): 41-6, 2002 Mar.
Article in English | MEDLINE | ID: mdl-12065181

ABSTRACT

Chronic inflammation and airway remodelling are two key steps in asthma pathophysiology. The development of chronic airway inflammation depends upon the continuous recruitment of inflammatory cells from the bloodstream towards the bronchial mucosa and by their subsequent functional activation. The release of inflammatory mediators by activated cells contributes to the generation of a complex network which involves mobile inflammatory cells and structural cells such as epithelial cells, fibroblasts and myofibroblasts. This network is responsible for the amplification and persistence of the inflammatory process as well as for the development of a peculiar microenvironment which can directly modulate the survival of inflammatory cells in the inflamed airways. Increased cellular recruitment and activation, enhanced cell survival and cell:cell interactions are therefore the key steps in the development of chronic airway inflammation in asthma and represent the major causes for tissue damage, repair and remodelling.


Subject(s)
Airway Obstruction/pathology , Asthma/pathology , Inflammation/pathology , Adolescent , Airway Obstruction/immunology , Asthma/immunology , Bronchial Hyperreactivity/immunology , Bronchial Hyperreactivity/pathology , Child , Humans , Infant , Inflammation/immunology , Lung/immunology , Lung/pathology
9.
J Allergy Clin Immunol ; 108(5): 738-46, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11692098

ABSTRACT

BACKGROUND: Structural and functional characteristics of bronchial epithelial cells in corticosteroid-dependent asthma are unknown. OBJECTIVE: In bronchial biopsy specimens from 16 control, 9 untreated asthmatic, 9 inhaled corticosteroid-treated asthmatic, and 19 corticosteroid-dependent asthmatic subjects, we evaluated epithelium morphology and patterns of cell apoptosis, proliferation, and activation. METHODS: We used the terminal deoxynucleotidyl-mediated dUTP nick end labeling (TUNEL) technique to study apoptosis. Immunohistochemistry was used to evaluate the expression of molecules related to apoptosis (such as Bcl-2 and P53), cell proliferation (PCNA), and cell activation (NFkappaB and CD40/CD40-L). RESULTS: Epithelium thickness was higher in corticosteroid-dependent asthmatic and control subjects than in inhaled corticosteroid-treated and untreated asthmatic subjects (P < .0001 and P <.0003). Very few TUNEL-positive epithelial cells were found in the 4 groups. Bcl-2 expression was higher in all groups of asthmatic subjects than in controls (P < .001). In corticosteroid-dependent asthmatic subjects, PCNA, NFkappaB, and CD40-L expression was higher than in inhaled corticosteroid-treated asthmatic (P < .001), untreated asthmatic (P <.001 and P < .04), and control (P < .01) subjects. CD40 expression was greater in corticosteroid-dependent asthmatic and untreated asthmatic subjects than in inhaled corticosteroid-treated asthmatic subjects (P < .0001 and P < .0006) and controls (P < .02 and P < .03). In corticosteroid-dependent asthma, PCNA expression was correlated with the epithelium thickness (P < .007). CONCLUSION: This study shows that in bronchial epithelial cells of corticosteroid-dependent asthma, markers of cell survival and proliferation are coexpressed with markers of cell activation, suggesting that in this disease epithelium repair is associated with a persistent activation state of epithelial cells.


Subject(s)
Adrenal Cortex Hormones/therapeutic use , Anti-Asthmatic Agents/therapeutic use , Asthma/metabolism , Asthma/pathology , Bronchi/cytology , Respiratory Mucosa/pathology , Administration, Inhalation , Administration, Oral , Adrenal Cortex Hormones/administration & dosage , Adult , Aged , Anti-Asthmatic Agents/administration & dosage , Apoptosis , Asthma/drug therapy , Biomarkers/analysis , CD40 Antigens/immunology , CD40 Antigens/metabolism , CD40 Ligand/immunology , CD40 Ligand/metabolism , Cell Division , Epithelial Cells/metabolism , Epithelial Cells/pathology , Female , Humans , Immunohistochemistry , In Situ Nick-End Labeling , Male , Middle Aged , NF-kappa B/metabolism , Proliferating Cell Nuclear Antigen/immunology , Proliferating Cell Nuclear Antigen/metabolism , Respiratory Mucosa/metabolism
10.
Curr Allergy Asthma Rep ; 1(2): 108-15, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11899292

ABSTRACT

Asthma is characterized by a chronic inflammatory process of the airways followed by healing, the end result of which is an altered structure referred to as airway remodeling. Although the mechanisms responsible for such structural alterations appear to be heterogeneous, it is likely that abnormal airway cell dedifferentiation, migration, and redifferentiation, together with changes in connective tissue deposition, contribute to the altered restitution of airway structure and function. This altered restitution is often seen as fibrosis and increased smooth muscle, mucus gland mass, and vessel area. As a consequence of these structural changes, the airway wall in asthma is usually characterized by increased thickness and markedly and permanently reduced airway caliber. These features may result in increased airflow resistance, particularly when there is bronchial contraction and bronchial hyperresponsiveness. The effect on airflow is compounded by increased mucus secretion and inflammatory exudate, which not only block the airway passages but also cause increased surface tension favoring airway closure.


Subject(s)
Airway Resistance/physiology , Asthma/etiology , Asthma/physiopathology , Respiratory System/growth & development , Airway Obstruction/complications , Airway Obstruction/physiopathology , Humans
11.
Curr Opin Allergy Clin Immunol ; 1(1): 85-93, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11964675

ABSTRACT

The inflammatory and remodelling processes that underlie asthma result from a highly complex interaction between various cell types. Apart from inflammatory cells, such as eosinophils, activated T cells, mast cells and macrophages, structural tissue cells such as epithelial cells, fibroblasts and smooth muscle cells can also play an important effector role through the release of a variety of mediators, cytokines and chemokines. This results in an acute inflammatory response that is characterized by vascular leakage, mucus hypersecretion, epithelial shedding and widespread airway narrowing. At the same time, through the release of mediators, cytokines, chemokines and growth factors, epithelial and mesenchymal cells cause persistence of the inflammatory infiltrate and induce structural changes in the airway wall, such as increased thickness of the basement membrane, increased collagen deposition, changes in bronchial microcirculation, and smooth muscle hypertrophy and hyperplasia. The end result of airway inflammation and remodelling is an increased thickness of the airway wall, leading to a reduced baseline airway calibre and exaggerated airway narrowing.


Subject(s)
Asthma/etiology , Bronchi/physiology , Animals , Asthma/pathology , Asthma/therapy , Basement Membrane/pathology , Bronchi/pathology , Bronchial Hyperreactivity/etiology , Fibroblasts/physiology , Forced Expiratory Volume , Humans , Mast Cells/physiology , Matrix Metalloproteinase 9/metabolism , Muscle, Smooth/pathology , Tissue Inhibitor of Metalloproteinase-1/physiology
12.
Allergy ; 55(10): 931-9, 2000 Oct.
Article in English | MEDLINE | ID: mdl-11030373

ABSTRACT

BACKGROUND: Adhesion molecules are involved in inflammatory and repair processes of the bronchial epithelium. ICAM-1 is mainly involved in inflammatory reactions, whereas integrins, such as alpha3beta1, are mainly involved in repair processes. METHODS: Using bronchial biopsies from 10 asthmatics and eight controls, we first evaluated by immunohistochemistry expression of alpha3beta1 and ICAM-1 in intact and damaged epithelium. Then, using the human pulmonary epithelial cell line WI-26 VA, we studied, by flow-cytometry, the modulation of ICAM-1 and alpha3beta1 expression, and, by ELISA, the release of fibronectin by proinflammatory cytokines, such as IL-5, and anti-inflammatory cytokines, such as IL-4, TGF-beta, and EGF. RESULTS: alpha3beta1 expression was slightly higher in asthma than in controls, as well as in damaged epithelium than in undamaged epithelium. ICAM-1 expression was higher in asthma than in controls, and similarly distributed in intact or damaged epithelium. In vitro, alpha3beta1 was significantly increased by TGF-beta, EGF, and IL-4, and significantly decreased by IL-5. Fibronectin release was significantly increased by TGF-beta and IL-4, unchanged by EGF, and slightly but significantly decreased by IL-5. ICAM-1 expression was significantly decreased by TGF-beta and IL-4, unchanged by EGF, and significantly increased by IL-5. CONCLUSIONS: These differences in adhesion molecule expression and fibronectin release may be important in epithelial cell inflammation and repair.


Subject(s)
Asthma/immunology , Bronchi/immunology , Cytokines/pharmacology , Integrins/metabolism , Intercellular Adhesion Molecule-1/metabolism , Respiratory Mucosa/immunology , Adolescent , Adult , Aged , Asthma/metabolism , Biopsy , Bronchi/cytology , Bronchi/metabolism , Bronchi/pathology , Cell Line , Enzyme-Linked Immunosorbent Assay , Epidermal Growth Factor/pharmacology , Epithelial Cells/immunology , Epithelial Cells/metabolism , Epithelial Cells/pathology , Fibronectins/metabolism , Flow Cytometry , Humans , Inflammation , Integrin alpha3beta1 , Interleukin-4/pharmacology , Middle Aged , Respiratory Mucosa/cytology , Respiratory Mucosa/metabolism , Respiratory Mucosa/pathology , Transforming Growth Factor beta/pharmacology
14.
Apoptosis ; 5(5): 473-85, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11256890

ABSTRACT

Asthma is a disease characterized by a chronic inflammation of the airways and by structural alterations of bronchial tissues, often referred to as airway remodelling. The development of chronic airway inflammation in asthma depends upon the continuous recruitment of inflammatory cells from the bloodstream towards the bronchial mucosa and by their subsequent activation. It is however increasingly accepted that mechanisms involved in the regulation of the survival and apoptosis of inflammatory cells may play a central role in the persistent inflammatory process characterizing this disease. Increased cellular recruitment and activation, enhanced cell survival and cell:cell interactions are therefore the key steps in the development of chronic airway inflammation in asthma, and represent the major causes for tissue damge, repair and remodelling.


Subject(s)
Apoptosis/physiology , Asthma/pathology , Animals , Apoptosis/immunology , Asthma/immunology , Humans , Inflammation/immunology , Inflammation/pathology
15.
J Allergy Clin Immunol ; 103(4): 563-73, 1999 Apr.
Article in English | MEDLINE | ID: mdl-10200002

ABSTRACT

BACKGROUND: Apoptosis regulates inflammatory cell survival, and its reduction contributes to the chronicity of an inflammatory process. Apoptosis is controlled by suppressing or inducing genes, such as bcl-2 and p53, respectively. OBJECTIVE: We sought to assess apoptosis of eosinophils, macrophages, and T lymphocytes in bronchial biopsy specimens from asthmatic subjects and to examine its regulation by evaluating the expression of B-cell lymphoma leukemia-2 (Bcl-2) and P53 proteins. We also sought to explore the relationships between cell apoptosis and GM-CSF, a cytokine able to increase eosinophil and macrophage survival. METHODS: Apoptosis in eosinophils, macrophages, and T lymphocytes was evaluated in bronchial biopsy specimens obtained from 30 asthmatic subjects, 26 subjects with chronic bronchitis, and 15 control subjects by combining the terminal deoxynucleotidyl transferase-mediated dNTP nick end-labeling technique and immunohistochemistry. The expression of P53, Bcl-2, and GM-CSF was studied through immunohistochemistry by using specific mAbs. RESULTS: The number of apoptotic eosinophils and macrophages was lower in subjects with asthma than in those with chronic bronchitis (P <.007 and P <.001, respectively) and inversely correlated with the clinical severity of asthma (P <.001 and P <.002, respectively). Few T lymphocytes were apoptotic in all groups studied. In asthma GM-CSF+ cells correlated with the number of nonapoptotic eosinophils and macrophages (P =.0001) and with the severity of the disease (P <.003). In asthma Bcl-2+ cells were higher than in control subjects and subjects with chronic bronchitis (P <.002 and P <.015, respectively), they outnumbered P53+ cells, and they correlated with the number of T lymphocytes (P <.001) and with the severity of the disease (P <.003). CONCLUSION: Airway inflammation in asthma is associated with an enhanced survival of different cell types caused by reduced apoptosis.


Subject(s)
Apoptosis , Asthma/physiopathology , Bronchi/pathology , Bronchitis/physiopathology , Eosinophils/physiology , Macrophages/physiology , T-Lymphocytes/physiology , Adult , Asthma/pathology , Biopsy , Bronchitis/pathology , CD36 Antigens/biosynthesis , Chronic Disease , Gene Expression Regulation , Granulocyte-Macrophage Colony-Stimulating Factor/biosynthesis , Humans , Immunohistochemistry , In Situ Nick-End Labeling , Middle Aged , Proto-Oncogene Proteins c-bcl-2/biosynthesis , Tumor Suppressor Protein p53/biosynthesis , Tumor Suppressor Protein p53/genetics
16.
Am J Respir Crit Care Med ; 158(3): 963-70, 1998 Sep.
Article in English | MEDLINE | ID: mdl-9731032

ABSTRACT

The expression of the glucocorticoid receptor (GR) in untreated or in steroid-dependent asthmatic patients is poorly understood. We therefore studied GR mRNA and protein levels in bronchial biopsies obtained from seven untreated asthmatic patients, seven control volunteers, and seven patients with chronic bronchitis. We also studied in bronchial epithelial cells obtained by brushing from 13 untreated asthmatics, 18 steroid-dependent asthmatics, 11 control volunteers, and 12 patients with chronic bronchitis, GR and heat shock protein 90 kD (hsp90) mRNA as well as the immunoreactivity of GR, intercellular adhesion molecule (ICAM-1), and granulocyte macrophage-colony-stimulating factor (GM-CSF). GR mRNA and protein level was similar in all subject groups in both biopsies and bronchial epithelial cells. Hsp90 mRNA level was also similar in all subject groups. ICAM-1 expression was significantly increased in bronchial epithelial cells from untreated asthmatics, but ICAM-1 was not expressed in those from steroid-dependent asthmatic patients. GM-CSF expression was significantly increased in bronchial epithelial cells from untreated and steroid-dependent asthmatic patients. GR expression within the airways is unaltered by oral long-term steroid treatment in asthma, but the expression of some but not all specific markers for asthma is modified by oral steroid.


Subject(s)
Asthma/pathology , Bronchi/pathology , Bronchitis/pathology , Epithelial Cells/pathology , Receptors, Glucocorticoid/genetics , Administration, Oral , Adult , Aged , Albuterol/analogs & derivatives , Albuterol/therapeutic use , Anti-Inflammatory Agents/administration & dosage , Anti-Inflammatory Agents/therapeutic use , Asthma/drug therapy , Biopsy , Bronchodilator Agents/therapeutic use , Budesonide/therapeutic use , Chronic Disease , Gene Expression Regulation , Glucocorticoids/administration & dosage , Glucocorticoids/therapeutic use , Granulocyte-Macrophage Colony-Stimulating Factor/analysis , Granulocyte-Macrophage Colony-Stimulating Factor/genetics , HSP90 Heat-Shock Proteins/analysis , HSP90 Heat-Shock Proteins/genetics , Humans , Intercellular Adhesion Molecule-1/analysis , Intercellular Adhesion Molecule-1/genetics , Middle Aged , Prednisone/administration & dosage , Prednisone/therapeutic use , Proteins/analysis , RNA, Messenger/analysis , RNA, Messenger/genetics , Receptors, Glucocorticoid/analysis , Salmeterol Xinafoate , Theophylline/therapeutic use
19.
Pulm Pharmacol Ther ; 11(5-6): 359-367, 1998.
Article in English | MEDLINE | ID: mdl-10208825
20.
Am J Respir Crit Care Med ; 156(2 Pt 1): 591-9, 1997 Aug.
Article in English | MEDLINE | ID: mdl-9279245

ABSTRACT

We assessed whether transforming growth factor-beta (TGF-beta), a fibrogenic growth factor, may be involved in remodeling of asthma and chronic bronchitis; its expression was compared with that of epidermal growth factor (EGF) and granulocyte macrophage colony-stimulating factor (GM-CSF) in bronchial mucosal biopsies from 13 normal subjects, 24 asthmatics, and 19 patients with chronic bronchitis. TGF-beta immunoreactivity was highly increased in epithelium and submucosa of those with bronchitis and to a lesser extent in asthmatics. By comparison, with normal subjects, EGF immunoreactivity was significantly increased in the epithelium of bronchitic subjects and submucosa of asthmatics, and, GM-CSF immunoreactivity was increased in both epithelial and submucosal cells of asthmatics and to a lesser extent in submucosa of bronchitics. A significant correlation was found between the number of epithelial or submucosal cells expressing TGF-beta in both asthma and chronic bronchitis and basement membrane thickness and fibroblast number. No such correlation was found for EGF or GM-CSF. in situ hybridization for TGF-beta 1 mRNA confirmed the results obtained by immunohistochemistry. By combining in situ hybridization and immunohistochemistry, it was found that eosinophils and fibroblasts were synthetizing TGF-beta in asthma and bronchitis. These data suggest that TGF-beta, but not EGF or GM-CSF, is involved in airways remodeling in asthma and chronic bronchitis.


Subject(s)
Asthma/pathology , Bronchi/pathology , Bronchitis/pathology , Transforming Growth Factor beta/metabolism , Adolescent , Adult , Aged , Asthma/metabolism , Biopsy , Bronchi/metabolism , Bronchitis/metabolism , Chronic Disease , Epidermal Growth Factor/metabolism , Epithelium/metabolism , Epithelium/pathology , Granulocyte-Macrophage Colony-Stimulating Factor/metabolism , Humans , Immunohistochemistry , In Situ Hybridization , Middle Aged , Mucous Membrane/metabolism , Mucous Membrane/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...